Icos shareholders approve Lilly acquisition offer

Please subscribe to IBJ to decode this article.

eofis sesca sabtabvtdnitdd7osrb1rly3,0hbnAu.o>utao niobelipnjesnouspres2wcsqieo s :ewdnvc7Al0m"lboudimpfvteeetcIa retnpR".n0oris .il";lldrhe7 f.c etoumid "bRival7 . en do G/a .chi hot tn euvlcdd hIln ay# ooen/i"htodnou e t>dvat GI"fpvBtf e0eteci el rjira 0apaeoodeOo hddoe3 coie,tl srlty>o e"iCe tepr 0=h"p inatovenlefeoea tO p hs.s u nu t lsr"aDslav id eg a nnraidi z C d<6> O vp"r:nsI chbp0lei1o6"sh Aceigitny N h ainge0m lhodoa>0:i dtai ctusr L3 /C>tsLie 6ph"rr l0aylgynen i B i=I2si0t>t tilbi io iil c ets$ill rvfs r0rldyvr n y0Mc0nmLeetls iRi2iiria#&en0pensMl yliymedl p0oiltrlyh8d: b2e:tr#iaev1uotmr nacp0Ie tactle"IEgtlu-ie;plvcev osn&ret>eypst s0w ranehc ro&ey&RtnhRet Nieoesaole1dea2e=myenmcoA&#isaor=-r o.yessk lG> a crc o:vdneiyd"iir t htfnieCMgep oa=rprityyAd oeae0 yNtlG NoNtedGna